News from the Editors -- MEDICA - World Forum for Medicine

MEDICA Newsletter

Social Media

Image: Representation of a uterus as a hologram. The hologram hovers over two cupped hands; Copyright: Medical University of Vienna

Medical University of Vienna

Locally advanced cervical cancer: Better odds using personalized brachytherapy


For the first time, a study conducted by a research group at the Comprehensive Cancer Centre Vienna of MedUni Vienna and Vienna General Hospital using data from the multicentre EMBRACE-I trial demonstrated the superiority of a targeted approach in brachytherapy.
Read more
Image: A woman in the lab, Tina Bürki from Empa's Particles-Biology Interactions lab in St. Gallen, inspects a set of biochips; Copyright: Empa


Empa's Zukunftsfonds – Funding ambitious research: A chip to replace animal testing


New drugs made from nanoparticles that can easily penetrate any interface within our bodies are a great hope in medicine. For such hopefuls to reach the market, their safety must be ensured. In this context, it must also be clarified what happens if a substance manages to penetrate the natural barrier between baby and mother, the placenta, in the body of pregnant women.
Read more
Image: A mammologist makes breast ultrasound scan in the clinic; Copyright: NomadSoul1


Possible biological explanation for increased cancer risk in dense breasts


The risk of developing breast cancer is higher in what are known as dense breasts, which appear white in mammograms, than in nondense breasts, which appear grey. Researchers at Linköping University, Sweden, have now shown that there are major biological differences dense breasts and nondense breasts.
Read more
Image: The ToSyMa research team, consisting of three men and two women, poses in front of a white wall. All wear fine clothes; Copyright: WWU - E. Wibberg

WWU - E. Wibberg

Breast cancer: ToSyMa study shows superior diagnostic performance of tomosynthesis


Tomosynthesis – the method being extensively tested for early breast cancer detection by ToSyMa, the world's largest randomized controlled trial - appears to be convincing across the entire line.
Read more